Medical Foods Market By Therapeutic Type (Pain Management, Sleep Management, Obesity and Hypertension, Cognitive Disorders, Viral Infections, Neuro-Degenerative Disorders, Inborn Errors of Metabolism), By Mode of Administration (Parenteral, Enteral, Others), By Application (Diabetic Neuropathy, ADHD, Depression, Alzheimer’s Disease, Nutritional Deficiency, Others), By Distribution Channel (Hospital Pharmacy, Retail pharmacy, and Online pharmacy) and Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Medical Foods Market was valued at $ 17.03 Bn in 2021 and is anticipated to grow at $ 29.67 Bn by 2028 recording a CAGR of 6.5% during the forecast period 2022-2028. Foods that are subjected to technological modifications either for protection or for changing over into prepared to-utilize/eat nourishments, disposing of relentless family unit strategies, are called “Medical Foods ". A portion of the cases is processed blends, dried out nourishments, pasta items, canned food, confectioneries, pastry shop, dairy items and breakfast nourishments. Manufacture of Medical Foods requires innovation application and apparatus, and thus, Medical Foods are costly. Modern players are engaged with the securing of little players which will additionally bolster the organization to grow and contact shoppers over the areas, the end-client enterprises are slanted towards item advancements through online life, magazines and different mediums keeping in mind the end goal to connect with clients. The limited time methodology helps in holding the current the clients and furthermore to recover new client base. With vital extensions, advertise players can center around entering into the creating economies to extend their business portfolio. Customers in creating nations are excited about investigating new item run offered to them and frame a substantial purchaser base. Setting up showcase in these rising economies is beneficial in view of moderately low set-up costs, simplicity of working together, and further lower variable cost to be caused. For example, In November 2017 BASF SE has teamed up with DIEM Labs to fortify the nearness in U.S. also, go into the therapeutic sustenances showcase. In November 2017 Ajinomoto has obtained Cambrooke Therapeutics, Inc. keeping in mind the end goal to upgrade the item arrangement of therapeutic nourishments. Rising interest for therapeutic sustenances from the locale will encourage high income age through this section. In September 2017 Kellogg has put resources into mushroom protein organization. Kellogg is a main player in the breakfast feast items. This will help in expanding the organization income and will permit likewise to concoct excellent therapeutic vaccines supplements. Medical Foods Market is classified on the basis of Therapeutic Type, By Mode of Administration, Application, Distribution Channel and geographical regions.  

Medical Foods Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market


The worldwide Medical Foods market is driven by an ascent in geriatric populace and increment in risk of chronic ailments around the world. There is a moving pattern toward enteral nourishment (ingestion through the gastrointestinal tract) parenteral nutrition absorption such as intravenous administration, for example, intravenous organization. The enteral organization is more secure when contrasted with the parenteral choice as there is a lesser danger of disease and it offers physiological benefits, for example, the upkeep of small digestive system mass and pancreatic capacity. Mechanical progressions have decreased the cost of enteral medication organization, influencing it to cost-effective. Hence, a move toward medical food and increment in demand for customized prescription in created nations are relied upon to fuel interest for medicinal foods sooner rather than later.

Key Features of the Reports

  • he report provides granular level information about the market size, regional market share, historic market (2016 to 2021) and forecast (2022 to 2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Medical Foods Market Segmentation

Therapeutic Type
  • Pain Management, Sleep Management
  • Obesity and Hypertension
  • Cognitive Disorders
  • Viral Infections
  • Neuro-Degenerative Disorders
  • Inborn Errors of Metabolism
Route of Administrat
  • Parenteral
  • Enteral
  • Others
  • Diabetic Neuropathy
  • ADHD
  • Depression
  • Alzheimer’s Disease
  • Nutritional Deficiency
  • Others
Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Market participants: Medical Foods Market 

Some of the players in Medical Foods Market

  • Danone SA (France)
  • Nestlé SA (Switzerland)
  • Abbott Laboratories (U.S.)
  • Mead Johnson & Company, LLC (U.S.)
  • Primus Pharmaceuticals Inc. (U.S.)
  • Targeted Medical Pharma Inc. (U.S.)
  • Fresenius Kabi AG (Germany)